Imprimis Pharmaceuticals (Nasdaq: IMMY) is a pharmaceutical company dedicated to delivering high-quality and innovative medicines to physicians and patients at affordable prices. We are pioneering a new commercial pathway in the pharmaceutical industry, using compounding pharmacies for the formulation and distribution of high-quality formulations that are supported by the clinical experience of physicians and their patients.
We offer proprietary compounded ophthalmic formulations. All of our innovative drug formulations are born from the clinical experience of physicians and pharmacist formulators. We are People-FocusedTM and believe our unique business model provides us with the opportunity to address unmet patient needs while delivering high quality and affordable medical solutions to physicians and patients. Learn more about about our approach.
We are committed to customer relationships, the highest quality standards, accessible innovation and solving the unmet needs in the markets we serve. We are delivering on the promise of our unique model and look forward to continuing to serve the needs of our customers with additional novel drug therapies within our full portfolio, and in turn grow our business. Our hope is that through the success of our business we will reduce healthcare costs and provide physicians and patients access to high quality, novel and previously unavailable medicines.
Extending our mission here and around the globe with U.S Ophthalmologists, Imprimis contributes to both local and international missions and indigent programs to patients in need every year.